Policy Analysis: Life Sciences
Published:

German scientists open access to E. coli gene database for use in drug discovery

Following the deadly outbreak of E. coli infections in Germany, scientists in Saarbruecken are providing free access to the pathogen’s genetic regulation data, to spur research into new antibiotics

Image: Bigstock

It only takes a few genes make the deadly enterohaemorrhagic form of Escherichia coli (EHEC) that is so dangerous to humans. If it were not for these genes, EHEC would hardly differ from the harmless (and indeed, useful) form of the bacterium which occurs naturally in the gastrointestinal system.

Bioinformatics specialists from the Saarbrücken Cluster of Excellence aim to exploit this similarity to find starting points for effective drugs against the EHEC pathogen. They have constructed EhecRegNet,...



Related subjects: Antibiotics, Germany, E.coli

The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 20 November 2015
The future of manufacturing: Industry 4.0 (Date to be confirmed)
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 29 September 2015
Views of 2030: Transport, manufacturing, education and health
In October 2014, members of the Science|Business Network of universities and companies met in Berlin to compare notes about the future of four key sectors in Europe. This is what they see coming.